• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BECTON DICKINSON, S.A. BD PHASEAL SECONDARY SET (C62); INTRAVASCULAR ADMINISTRATION SET

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BECTON DICKINSON, S.A. BD PHASEAL SECONDARY SET (C62); INTRAVASCULAR ADMINISTRATION SET Back to Search Results
Catalog Number 515312
Device Problem Leak/Splash (1354)
Patient Problem No Consequences Or Impact To Patient (2199)
Event Date 02/02/2021
Event Type  malfunction  
Event Description
It was reported that the bd phaseal¿ secondary set (c62) leaked cytostatic medicine from the tube connection.The following information was provided by the initial reporter: in the pharmacy they prepared cystostatics with phaseal and c62 (several years already).Now they realized leakage from the connecting point of connector and the tube.This product is destroyed as it's cystostatic contaminated.
 
Manufacturer Narrative
(b)(4).Investigation summary: one photo was provided to our quality team for investigation.The final product for lot ta12092 is assembled and packaged at a supplier site.We notified the supplier of the reported issue and provided the photo for evaluation.Upon visually inspecting the photo that was received, a drop of liquid is observed outside the set, near the y-site.There is no evidence of damage or a break at this connection.Retained samples were used for additional evaluation, there were no visual defects noted and all product was manufactured according to specification.It was thought that excessive force by the operator when connecting the connector piece to the y-site could have been a potential cause for this incident.All testing was reviewed for the reported lot, including leakage, torque, and inspection results with no issues identified related to the reported malfunction.Without the physical sample we cannot verify any damage to the product or determine where the liquid originated therefore we were not able to identify a definitive root cause related to the manufacturing process at this time.Complaints for this device and defect will continue to be monitored by our quality team for signs of emerging trends.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
BD PHASEAL SECONDARY SET (C62)
Type of Device
INTRAVASCULAR ADMINISTRATION SET
Manufacturer (Section D)
BECTON DICKINSON, S.A.
camino de valdeolivia
s/n
san agustin de guadalix
MDR Report Key11382437
MDR Text Key280447911
Report Number3003152976-2021-00110
Device Sequence Number1
Product Code ONB
Combination Product (y/n)N
PMA/PMN Number
NA
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,other,user facility
Type of Report Initial
Report Date 02/08/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Other
Device Expiration Date02/29/2024
Device Catalogue Number515312
Device Lot NumberTA12092
Was Device Available for Evaluation? No
Initial Date Manufacturer Received 02/02/2021
Initial Date FDA Received02/25/2021
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
-
-